A new meningitis vaccine tested in two African countries has shown promise in the fight against the disease, eliciting immune responses against five main strains. A new study published by the New ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenicity of NmCV-5, a ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

Please provide your email address to receive an email when new articles are posted on . A pentavalent vaccine against meningitis continued to show promise in a phase 3 trial in Africa’s meningitis ...

In a recent study published in The New England Journal of Medicine, researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine compared to the World Health ...

University of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

Successful trials in Africa of NmCV-5 vaccine open the door to affordable treatment for disease that kills 250,000 people a year An effective, affordable meningitis vaccine has been successfully ...